Kuwait City: A large batch of Sotrovimab drugs, which is used to treat mild to moderate cases of Covid-19, arrived in Kuwait. The drug will be distributed to hospitals specialized in treating corona within the next two weeks, after setting up the treatment protocol. Sotrovimab is a monoclonal immune response drug and is utilized to treat gentle to direct instances of Covid-19 in grown-ups and kids (12 years and over and weighing somewhere around 40 kilograms) in danger of Covid-19, for example, individuals 65 years old or more established, or the individuals who experience the ill effects of certain ailments, noticing that this medication isn't utilized for Covid-19 patients who are getting emergency clinic treatment or who need oxygen treatment because of their contamination with the Covid-19 infection.
Lorem ipsum dolor sit amet, consectetur adipisicing elit. Velit omnis animi et iure laudantium vitae, praesentium optio, sapiente distinctio illo?